KalVista Pharmaceuticals (KALV) Net Margin (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Net Margin of 105.51% in Q3 2025, down 129.45% quarter-over-quarter from 358.27% in Q2 2025.
KalVista Pharmaceuticals' Net Margin history runs 8 years deep, the most recent figure standing at 105.51% for Q3 2025.
- In Q3 2025, Net Margin changed N/A year-over-year to 105.51%; the TTM figure through Jul 2025 stood at 90.75% (up 65066.0% YoY), while the FY2025 annual figure was 834.62%, down 72930.0% from the prior year.
- Net Margin came in at 105.51% for Q3 2025 at KalVista Pharmaceuticals, down from 358.27% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 358.27% in Q2 2025 to a low of 105.51% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | -105.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -105.51% |
| Apr 30, 2025 | 358.27% |
| Apr 30, 2020 | -224.74% |
| Jan 31, 2020 | -783.26% |
| Oct 31, 2019 | -224.08% |
| Jul 31, 2019 | -266.37% |
| Apr 30, 2019 | -371.80% |
| Jan 31, 2019 | -152.62% |
| Oct 31, 2018 | -83.85% |
| Jul 31, 2018 | -186.12% |
| Apr 30, 2018 | -13.57% |
| Jan 31, 2018 | -224.54% |
| Oct 31, 2017 | -442.41% |
| Jul 31, 2017 | -5,133.33% |
| Apr 30, 2017 | -3,685.96% |
| Jan 31, 2017 | -3,167.34% |
| Oct 31, 2016 | -2,152.79% |
| Jul 31, 2016 | -458.97% |
| Mar 31, 2016 | -94,342.86% |
| Dec 31, 2015 | -80,800.00% |
| Sep 30, 2015 | -71,314.29% |
| Jun 30, 2015 | -83,342.86% |
| Mar 31, 2015 | -74,057.14% |
| Sep 30, 2014 | -39,240.00% |
| Jun 30, 2014 | -50,360.00% |
| Mar 31, 2014 | -33,583.33% |